We are live on ! Find out more
PFA

Pathway Financial Advisers Portfolio holdings

AUM $354M
1-Year Est. Return 21.65%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+21.65%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$278M
AUM Growth
+$15.1M
Cap. Flow
-$1.85M
Cap. Flow %
-0.67%
Top 10 Hldgs %
21.19%
Holding
504
New
38
Increased
151
Reduced
174
Closed
56

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.39M
2
ALL icon
Allstate
ALL
+$1.29M
3
AVGO icon
Broadcom
AVGO
+$1.16M
4
BX icon
Blackstone
BX
+$575K
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$503K

Sector Composition

Rank Sector Weight
1 Technology 12.15%
2 Financials 11.45%
3 Healthcare 10.53%
4 Industrials 9.19%
5 Energy 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPD icon
1
Enterprise Products Partners
EPD
$82.5B
$7.59M 2.73%
260,120
-452
-0.2% -$12.4K
JPM icon
2
JPMorgan Chase
JPM
$947B
$6.94M 2.5%
34,638
-1,978
-5% -$357K
STLD icon
3
Steel Dynamics
STLD
$36.1B
$6.85M 2.47%
46,198
-3,692
-7% -$464K
AVGO icon
4
Broadcom
AVGO
$1.82T
$6.06M 2.18%
45,750
-9,390
-17% -$1.16M
PEP icon
5
PepsiCo
PEP
$191B
$5.94M 2.14%
33,965
+716
+2% +$121K
ABBV icon
6
AbbVie
ABBV
$454B
$5.9M 2.12%
32,397
-1,710
-5% -$295K
DUK icon
7
Duke Energy
DUK
$100B
$5.62M 2.02%
58,087
-456
-0.8% -$43.3K
OKE icon
8
Oneok
OKE
$56.4B
$4.84M 1.74%
60,398
-1,408
-2% -$103K
CSCO icon
9
Cisco
CSCO
$452B
$4.6M 1.66%
92,244
+464
+0.5% +$23.1K
O icon
10
Realty Income
O
$61.1B
$4.52M 1.63%
83,591
+3,984
+5% +$216K
PG icon
11
Procter & Gamble
PG
$346B
$4.44M 1.6%
27,355
-2,183
-7% -$342K
ETY icon
12
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.26B
$4.28M 1.54%
320,396
+10,703
+3% +$136K
IBM icon
13
IBM
IBM
$204B
$4.13M 1.49%
21,626
-1,151
-5% -$210K
AAPL icon
14
Apple
AAPL
$4.95T
$4.12M 1.48%
24,032
-1,974
-8% -$359K
VZ icon
15
Verizon
VZ
$198B
$4.1M 1.48%
97,772
+6,801
+7% +$274K
SO icon
16
Southern Company
SO
$109B
$4.06M 1.46%
56,591
-1,219
-2% -$84.1K
LMT icon
17
Lockheed Martin
LMT
$134B
$4.06M 1.46%
8,924
-217
-2% -$95.1K
MSFT icon
18
Microsoft
MSFT
$2.89T
$3.87M 1.39%
9,195
-98
-1% -$39.7K
CVX icon
19
Chevron
CVX
$378B
$3.82M 1.38%
24,242
+556
+2% +$83.9K
ENB icon
20
Enbridge
ENB
$121B
$3.82M 1.38%
105,574
+5,212
+5% +$185K
SCHD icon
21
Schwab US Dividend Equity ETF
SCHD
$103B
$3.81M 1.37%
141,666
+22,584
+19% +$583K
AMGN icon
22
Amgen
AMGN
$203B
$3.74M 1.35%
13,167
-262
-2% -$76.7K
BNS icon
23
Scotiabank
BNS
$106B
$3.68M 1.33%
71,156
+4,937
+7% +$237K
MDT icon
24
Medtronic
MDT
$108B
$3.36M 1.21%
38,553
+2,557
+7% +$218K
JNJ icon
25
Johnson & Johnson
JNJ
$641B
$3.23M 1.16%
20,399
-410
-2% -$65.3K

Similar funds

Pathway Financial Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Pathway Financial Advisers held 504 positions worth $278M, up 5.8% from $263M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Pathway Financial Advisers's Q1 2024 filing shows 38 new, 151 increased, 174 reduced and 56 closed positions. Its largest new stake was DoubleLine Yield Opportunities Fund: 35,973 shares worth $573K. The largest sale was Bristol-Myers Squibb, an estimated $1.39M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • Pathway Financial Advisers's largest Q1 2024 buy was DoubleLine Yield Opportunities Fund: 35,973 shares worth $573K.
  • Pathway Financial Advisers added most to XPLR Infrastructure LP in Q1 2024, an estimated $1.01M increase.
  • Pathway Financial Advisers's biggest Q1 2024 reduction was Bristol-Myers Squibb, cutting an estimated $1.39M.
  • Pathway Financial Advisers fully exited Sysco in Q1 2024, selling an estimated $200K.
  • Pathway Financial Advisers's ten largest holdings make up 21% of its $278M portfolio in Q1 2024.
  • Pathway Financial Advisers opened 38 new positions and closed 56 in Q1 2024.
  • Pathway Financial Advisers's portfolio value rose 5.8% quarter-over-quarter to $278M.

Based on Pathway Financial Advisers's 13F filing for Q1 2024, filed 29 May 2024.